蓝丰生化盘中涨停，已连收4个涨停板，截至9:53，该股报7.81元，换手率28.06%，成交量7442.11万 股，成交金额5.58亿元，涨停板封单金额为1.16亿元。连续涨停期间，该股累计上涨46.53%，累计换手 率为59.06%。最新A股总市值达27.77亿元，A股流通市值20.71亿元。 龙虎榜数据显示，该股因连续三个交易日内，涨幅偏离值累计达20%上榜龙虎榜1次，买卖居前营业部 中，机构净卖出1250.06万元，营业部席位合计净买入3245.51万元。 公司发布的半年报数据显示，上半年公司共实现营业收入11.96亿元，同比增长40.89%，实现净利 润-4477.89万元，同比增长67.87%，基本每股收益为-0.1193元。（数据宝） 注：本文系新闻报道，不构成投资建议，股市有风险，投资需谨慎。 （文章来源：证券时报网） 近日该股表现 | 日期 | 当日涨跌幅（%） | 换手率（%） | 主力资金净流入（万元） | | --- | --- | --- | --- | | 2025.09.24 | 10.08 | 3.06 | 1710.24 | | 2025.09.23 | 10.07 | 18. ...

每经AI快讯，9月25日，蓝丰生化涨停走出4连板，4天累计涨幅达46.53%。 （文章来源：每日经济新闻） ...

近日安徽旭合新能源（蓝丰生化控股子公司）"一种0BB电池IV特性测试装置"（专利号： CN202510424709.2）获国家发明专利，彰显蓝丰生化"农化+新能源"双主业战略的精准布局。该专利装 置直击行业痛点，为高效光伏产品生产提供关键技术支撑。这一成果与旭合新能源已实现26.5%量产效 率的N型TOPCon电池技术形成协同，进一步完善技术矩阵。此次突破是蓝丰生化控股布局的重要成 果。自2023年9月以6752万元收购旭合新能源51%股权后，蓝丰生化持续赋能其发展，不仅提供超6.5亿 元融资担保，更助力引入战略投资者增资扩股，目前旭合新能源已建成2.5GW电池片与1GW组件产 能，手握47项授权专利。蓝丰生化的新能源转型战略正加速落地，行业竞争力持续巩固。 ...

龙头点睛：光刻胶板块掀起涨停潮 今日（9月24日）28股封单资金均超过1亿元。 涨停战场：3股封单资金均超5亿元 据证券时报·数据宝统计，从收盘涨停板封单量来看，蓝丰生化（002513）、启迪环境（000826）、华 软科技（002453）排名前三，封单量依次为51.82万手、36.68万手、33.88万手；TCL中环（002129）、 杭钢股份（600126）、渝开发（000514）、红豆股份（600400）紧随其后，封单量均在20万手以上。 从连续涨停天数看，华软科技斩获4连板；蓝丰生化、联美控股（600167）、向日葵实现3连板；另有张 江高科（600895）、立昂微（605358）、长川科技（300604）、南京港（002040）等2连板。 以封单金额计算，今日28股封单资金均超过1亿元。北方华创（002371）、通富微电（002156）、张江 高科排名前三，依次为8.74亿元、6.03亿元、5.03亿元；立昂微、蓝丰生化、长川科技、华软科技随 后，封单资金均在3亿元及以上。 北方华创最新收盘价为460.68元/股，1.9万手封单。盘后龙虎榜数据显示，今日合计净卖出8662万元。 深股通买入8.15亿 ...

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。 证券之星消息，9月24日农化制品板块较上一交易日上涨0.07%，蓝丰生化领涨。当日上证指数报收于 3853.64，上涨0.83%。深证成指报收于13356.14，上涨1.8%。农化制品板块个股涨跌见下表： 从资金流向上来看，当日农化制品板块主力资金净流入1811.04万元，游资资金净流出5803.06万元，散 户资金净流入3992.02万元。农化制品板块个股资金流向见下表： ...

Core Viewpoint - The stock of Lanfeng Biochemical has experienced a significant surge, achieving three consecutive daily limit-ups, with a total increase of 33.21% during this period [1] Company Performance - The company reported a total revenue of 1.196 billion yuan for the first half of the year, representing a year-on-year growth of 40.89% [1] - The net profit for the same period was -44.78 million yuan, showing a year-on-year increase of 67.87% [1] - The basic earnings per share stood at -0.1193 yuan [1] Stock Market Activity - As of 9:25 AM, the stock price was 7.10 yuan, with a turnover rate of 1.58% and a trading volume of 4.1995 million shares, amounting to a transaction value of 29.82 million yuan [1] - The stock's total market capitalization reached 2.525 billion yuan, with a circulating market value of 1.883 billion yuan [1] - The stock was listed on the Dragon and Tiger List due to a cumulative price deviation of 20% over three trading days, with institutional net selling of 12.50 million yuan and a total net buying of 32.46 million yuan from brokerage seats [1] Recent Stock Performance - On September 23, the stock had a daily increase of 10.07% with a turnover rate of 18.17% and a net inflow of 29.47 million yuan [2] - On September 22, the stock rose by 9.94% with a turnover rate of 9.77% and a net inflow of 43.24 million yuan [2] - The stock showed fluctuations in previous days, including a slight increase of 0.38% on September 11 and a decrease of 1.86% on September 18 [3]

Group 1 - The core point of the article is that Lanfeng Biochemical has experienced a significant stock price increase, achieving a limit-up and a three-day consecutive rise [2] - Over the past three days, Lanfeng Biochemical's stock has accumulated a total increase of 33.21% [2]

Core Viewpoint - The company, Bluefeng Biochemical, announced that its stock price experienced an abnormal fluctuation, with a cumulative closing price increase exceeding 20% over two consecutive trading days on September 22 and 23, 2025 [1] Summary by Relevant Sections - Stock Price Movement - The stock price of Bluefeng Biochemical showed a significant increase, with a cumulative rise of over 20% in the closing prices on September 22 and 23, 2025, indicating unusual trading activity [1] - Company Disclosure - The company confirmed that there are no corrections or supplements needed for previously disclosed information, and it has not identified any recent media reports that could have significantly impacted its stock price [1]

江苏蓝丰生物化工股份有限公司 关于公司股票交易异常波动的公告 证券代码：002513 证券简称：蓝丰生化 公告编号：2025-056 本公司及董事会全体成员保证公告内容真实、准确和完整，不存在虚假记 载、误导性陈述或者重大遗漏。 一、股票交易异常波动情况 江苏蓝丰生物化工股份有限公司（以下简称"公司"）股票交易价格于 2025 年 9 月 22 日、2025 年 9 月 23 日连续两个交易日收盘价格涨幅偏离值累计超过 20%，根据《深圳证券交易所交易规则》等有关规定，属于股票交易异常波动的 情形。 5、除上述事项外，公司、控股股东和实际控制人不存在关于本公司应披露 1 而未披露的重大事项，或处于筹划阶段的重大事项。 6、经核查，公司控股股东、实际控制人在股票异动期间不存在买卖公司股 票的行为。 二、公司关注并核实情况的说明 针对公司股票交易异常波动，公司对有关事项进行了核查，现就有关情况说 明如下： 1、公司前期披露的信息不存在需要更正、补充之处。 2、公司未发现近期有公共媒体报道了可能或已经对本公司股票交易价格产 生较大影响的未公开重大信息。 3、公司目前经营情况正常，内外部经营环境未发生重大变化。 4、 ...

Core Viewpoint - The company, Bluefeng Biochemical, announced that its stock experienced an abnormal trading fluctuation with a cumulative closing price deviation exceeding 20% over two consecutive days, indicating potential market volatility [1] Group 1: Company Performance - The company confirmed that its operational status remains normal and that there have been no significant changes in the internal or external environment [1] - There are no undisclosed significant information that the company is required to disclose [1] Group 2: Stock Activity - The controlling shareholder and actual controller did not engage in any buying or selling of the company's stock during the period of abnormal trading [1] - The company has approved a restricted stock incentive plan related to its stock [1] Group 3: Investor Advisory - The company advises investors to pay attention to official disclosure channels and to be cautious of investment risks [1]